Subsequent studies also examining data from the FDA Adverse Event Reporting System (FDA AERS) reported an increase in reporting rates of PDAC cases in GLP-1RA users over a broader study period 33,34
Please note: Those with government insurance, like Medicare, Medicaid, or VA benefits, are not eligible for these discount programs
Retatrutide is a triple agonist, meaning it activates three distinct hormone receptors GLP-1, GIP, and glucagon
22 Taken together, these mixed results tell us that we need to be careful about picking the right patients, develop good biomarkers, and pay attention to drug specific properties in future studies
While some preclinical research has explored potential immunomodulatory effects of GLP-1 receptor agonists, there is currently insufficient clinical evidence to establish this as a mechanism for systemic symptoms in patients taking tirzepatide
Prescription weight loss medications offer significant benefits for long-term weight management
